Gianluca Ianiro, from Gemelli Hospital in Rome, discusses the key determinants of success of FMT in the treatment of C. Difficile infections and other conditions.
Industry
Sponsored by
Lallemand launches Expert’Biome™ CDMO to support partners in their development of next-generation strains.
The findings suggest that Dau-d4 can supplement current DPP4 treatment approaches for type 2 diabetes.
The findings of a recent study may help identify targets for the prevention or treatment of rheumatoid arthritis and other inflammatory conditions.
Industry
Sponsored by
A new remarkable role into Vaginal microbiome.
Persephone to utilize the Bacteroides technology for the rapid generation of therapeutics from its planned and ongoing biomarker studies, including the ARGONAUT study.
Vegim Zhaku, from Tetovo University Faculty of Medicine, Macedonia, discussed the case of a male patient with palpitations, shortness of breath, epigastric discomfort and flatulence.
The new research and development project engaged by MICRO s.r.l.
The findings of a recent study suggest that microbial consortia such as MET-2 may be effective strategies to keep intestinal pathogens and antibiotic-resistant organisms at bay.
The findings of a recent study uncover how gut microbes may contribute to trigger GVHD, suggesting potential targets for therapies.
